Hohimer Wealth Management »

Summit Therapeutics shares owned by Hohimer Wealth Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Hohimer Wealth Management from 13F filings

Historical chart of Hohimer Wealth Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Hohimer Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Hohimer Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.9M 339k 14.57

More positions owned by Hohimer Wealth Management

Microsoft Corporation Put Option (MSFT)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Growth Etf (VUG)
Amazon Put Option (AMZN)
Dell Technologies CL C (DELL)
Broadcom (AVGO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Tidal Trust Iii Alki Consolidate
Agnico Call Option (AEM)
First Majestic Silver Corp Put Option (AG)
Vanguard Index Fds Value Etf (VTV)
Alphabet Cap Stk Cl A (GOOGL)
Alamos Gold Com Cl A (AGI)

View all positions for Hohimer Wealth Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics